Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jun 11 | JANX | Janux Therapeutics, Inc. | AGRANT | 5,500 | — | — | +88.0% | Open the original filing on SEC.gov |
| Jun 9 | BCAX | Bicara Therapeutics Inc. | AGRANT◆ | 19,475 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | PBLS | Parabilis Medicines, Inc. | AGRANT◆ | 20,215 | — | — | — | Open the original filing on SEC.gov |
| May 28 | TYRA | Tyra Biosciences, Inc. | AGRANT◆ | 13,160 | — | — | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | SEPN | Septerna, Inc. | AGRANT◆ | 16,623 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | JANX | Janux Therapeutics, Inc. | AGRANT◆ | 11,667 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | JANX | Janux Therapeutics, Inc. | AGRANT | 3,750 | — | — | +150.0% | Open the original filing on SEC.gov |
| Jun 9, 2025 | BCAX | Bicara Therapeutics Inc. | AGRANT◆ | 23,746 | — | — | — | Open the original filing on SEC.gov |
| May 29, 2025 | TYRA | Tyra Biosciences, Inc. | AGRANT◆ | 22,200 | — | — | — | Open the original filing on SEC.gov |